For research use only
| Cat No. | ABC-TC0169 |
| Product Type | Human Leukemia Cell Lines |
| Cell Type | Lymphoblastoid |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Multiple Myeloma |
| Product Code | COLO-775, Human Melanoma Cell Line COLO-775, COLO 775, COLO775, COLO-0775, Malignant Skin Cancer Cells, Human Melanoma Culture |
Human leukaemia. COLO 775 was established in 1990 from the peripheral blood cells of a 57 year old female with chronic myelogenous leukaemia.
COLO-775 cells are initially thought to originate from the peripheral blood of a 57-year-old African American female patient with chronic myelogenous leukemia. The COLO-775 cell line produces IgG lambda (derived from the parent cell line), and the cell type is B-cell. It is lymphoblastoid and exhibits a suspension growth pattern. The COLO-775 cell has a modal number of 65 chromosomes with an XXY karyotype and exhibits various sequence variations, including gene fusions and multiple mutations. In routine cell culture and experimental workflows, proper COLO 775 contamination control is important to maintain culture stability and ensure consistent and reproducible research results. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | COLO-775, Human Melanoma Cell Line COLO-775, COLO 775, COLO775, COLO-0775, Malignant Skin Cancer Cells, Human Melanoma Culture |
| Species | Human |
| Cat.No | ABC-TC0169 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphoblastoid |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Multiple Myeloma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Leukemia Cell Lines |
COLO-775 is commonly used as an in vitro system for investigating the molecular and cellular characteristics of leukemia cells, particularly signaling pathways associated with the BCR-ABL1 fusion protein. This cell line supports studies of cell proliferation, signaling regulation, gene expression, and drug response mechanisms.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
